hydroxychloroquine has been researched along with Complications of Diabetes Mellitus in 11 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Consequently, hydroxychloroquine and topical glucocorticoids therapy were initiated with reported improvement in pruritus, erythema, and scale." | 3.74 | Chronic cutaneous lupus erythematosus in vitiligo. ( Bossenbroek, NM; Johnson, H; Meehan, SA; Pomeranz, MK; Robles, M; Rosenman, K, 2008) |
| " Subcutaneous administration of methotrexate was more effective than the oral administration at the same dosage in patients suffering from active rheumatoid arthritis." | 3.74 | [What's new in internal medicine?]. ( Francès, C, 2008) |
| "Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action." | 1.62 | Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story. ( Catrinoiu, D; Ceriello, A; Rizzo, M; Stoian, AP, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Caldas, R | 1 |
| Guimarães, MJ | 1 |
| Rodrigues, AP | 1 |
| Araújo, C | 1 |
| Infante, M | 1 |
| Ricordi, C | 1 |
| Fabbri, A | 1 |
| Chee, YJ | 1 |
| Tan, SK | 1 |
| Yeoh, E | 1 |
| Nasir, N | 1 |
| Farooqi, J | 1 |
| Mahmood, SF | 1 |
| Jabeen, K | 1 |
| Stoian, AP | 1 |
| Catrinoiu, D | 1 |
| Rizzo, M | 1 |
| Ceriello, A | 1 |
| Grewal, SK | 1 |
| Rubin, C | 1 |
| Rosenbach, M | 1 |
| Ekwom, PE | 1 |
| Johnson, H | 1 |
| Bossenbroek, NM | 1 |
| Rosenman, K | 1 |
| Meehan, SA | 1 |
| Robles, M | 1 |
| Pomeranz, MK | 1 |
| Goucha, S | 1 |
| Khaled, A | 1 |
| Kharfi, M | 1 |
| Fazaa, B | 1 |
| Zermani, R | 1 |
| Ben Jilani, S | 1 |
| Kamoun, MR | 1 |
| Francès, C | 1 |
| Petri, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diagnosis of Invasive Pulmonary Aspergillosis (IPA) - Specific Testing in Bronchial Secretions Versus Bronchoalveolar Fluid in Patients With and Without COVID-19[NCT04848831] | 100 participants (Anticipated) | Observational | 2021-06-01 | Not yet recruiting | |||
| [NCT00005436] | 0 participants | Observational | 1991-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for hydroxychloroquine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic.
Topics: Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diabetes Complications; | 2020 |
Dissecting the interaction between COVID-19 and diabetes mellitus.
Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Blood Glucose; Chloroquine; Comorbidity; COVID- | 2020 |
Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.
Topics: Antirheumatic Agents; Baltimore; Blood Glucose; Cohort Studies; Diabetes Complications; Diabetes Mel | 1996 |
8 other studies available for hydroxychloroquine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Generalised papular variant of elastolytic giant cell granuloma.
Topics: Aged; Diabetes Complications; Granuloma Annulare; Granuloma, Giant Cell; Griseofulvin; Humans; Hydro | 2019 |
COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.
Topics: Aged; Aged, 80 and over; Azithromycin; Coronavirus Infections; COVID-19; Diabetes Complications; Fem | 2020 |
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story.
Topics: Blood Glucose; COVID-19; COVID-19 Drug Treatment; Diabetes Complications; Diabetes Mellitus; Glycemi | 2021 |
Antimalarial therapy for granuloma annulare: Results of a retrospective analysis.
Topics: Adult; Aged; Antimalarials; Dermatologic Agents; Diabetes Complications; Dyslipidemias; Female; Gluc | 2017 |
Systemic lupus erythematosus (SLE) at the Kenyatta National Hospital.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Arthritis; Black People; Child; Data Collection; Diabete | 2013 |
Chronic cutaneous lupus erythematosus in vitiligo.
Topics: Autoimmunity; Carcinoma, Squamous Cell; Clobetasol; Diabetes Complications; Diagnostic Errors; Drug | 2008 |
Granuloma annulare.
Topics: Administration, Cutaneous; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Antirh | 2008 |
[What's new in internal medicine?].
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Bacteriophages; Body Mass | 2008 |